Medicis Pharmaceutical Corp (NYSE:MRX)
CAPS Rating:
A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.
RSS Headlines
Fool UK
Recs
$25+/share